Fleury’s buyout of women’s health lab Femme faces Brazil CADE analysis
Brazil’s competition regulator is reviewing the proposed acquisition by Fleury, a São Paulo–based healthcare company, of competitor Femme, a laboratory network focused exclusively on women’s health. The parties said the deal...To view the full article, register now.
Already a subscriber? Click here to view full article